Table 2.

Clinical features description.

Feature	Description
Diagnosis age	Patient age when diagnosed with AML
Bone marrow blast %	Percentage of blasts in the bone marrow
Mutation count	Number of genetic mutations observed
PB blast %	Percentage of blasts in peripheral blood
WBC	White blood cell count
Gender	Patient gender
Race	Whether the patient is white or not
Cytogenetic info	Cytogenetic information that the specialist used in diagnosing the patient
ELN risk classification	ELN risk groups (favorable, intermediate, and adverse)
Treatment intensity classification	The intensity of treatment received by the patient (target, regular, low-intensity, or high-intensity therapy)
Overall survival status	Patient survival status (living or deceased).